Literature DB >> 15795328

Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response.

Takuma Aoyama1, Takashi Matsui, Mikhail Novikov, Jongsun Park, Brian Hemmings, Anthony Rosenzweig.   

Abstract

BACKGROUND: Serum- and glucocorticoid-responsive kinase-1 (SGK1), a serine-threonine kinase that is highly expressed in the heart, has been previously reported to regulate sodium channels. Because SGK1 is a PI 3-kinase-dependent kinase with structural homology to Akt, we examined its regulation in the heart and its effects on cardiomyocyte (CM) apoptosis and hypertrophy in vitro. METHODS AND
RESULTS: Rats were subjected to aortic banding, and expression of total and phosphorylated SGK1 was examined. Both phospho- and total SGK1 increased 2 to 7 days after banding. Phospho-SGK1 was also upregulated in CMs stimulated in vitro with IGF-I or phenylephrine. Infection of CMs with an adenoviral vector encoding constitutively active SGK1 (Ad.SGK1.CA) inhibited apoptosis after serum-deprivation or hypoxia (P<0.05), whereas expression of kinase-dead SGK1 (Ad.SGK1.KD) increased it and partially mitigated the protective effects of IGF-I (P<0.05). SGK1 activation was also sufficient to increase cell size, protein synthesis, sarcomere organization, and ANF expression both at baseline and in response to phenylephrine but was not necessary for the hypertrophic response to phenylephrine. Evaluation of potential downstream signaling pathways demonstrated that SGK1 induces phosphorylation of tuberin, p70s6kinase, and GSK3beta in CMs, which may contribute to its effects.
CONCLUSIONS: SGK1 is dynamically regulated during acute biomechanical stress in the heart and inhibits CM apoptosis while enhancing the hypertrophic response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795328     DOI: 10.1161/01.CIR.0000160352.58142.06

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Authors:  Pontus Boström; Nina Mann; Jun Wu; Pablo A Quintero; Eva R Plovie; Daniela Panáková; Rana K Gupta; Chunyang Xiao; Calum A MacRae; Anthony Rosenzweig; Bruce M Spiegelman
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

2.  Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.

Authors:  Andrea B Sherk; Daniel E Frigo; Christine G Schnackenberg; Jeffrey D Bray; Nicholas J Laping; Walter Trizna; Marlys Hammond; Jaclyn R Patterson; Scott K Thompson; Dmitri Kazmin; John D Norris; Donald P McDonnell
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 3.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 4.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

5.  Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP.

Authors:  Larissa Belova; Sanjay Sharma; Deanna R Brickley; Jeremy R Nicolarsen; Cam Patterson; Suzanne D Conzen
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

Review 6.  New Insights Into the Role of mTOR Signaling in the Cardiovascular System.

Authors:  Sebastiano Sciarretta; Maurizio Forte; Giacomo Frati; Junichi Sadoshima
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

7.  PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury.

Authors:  Tomohisa Nagoshi; Takashi Matsui; Takuma Aoyama; Annarosa Leri; Piero Anversa; Ling Li; Wataru Ogawa; Federica del Monte; Judith K Gwathmey; Luanda Grazette; Brian A Hemmings; Brian Hemmings; David A Kass; Hunter C Champion; Anthony Rosenzweig
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

8.  Inhibition of miR-15 protects against cardiac ischemic injury.

Authors:  Thomas G Hullinger; Rusty L Montgomery; Anita G Seto; Brent A Dickinson; Hillary M Semus; Joshua M Lynch; Christina M Dalby; Kathryn Robinson; Christianna Stack; Paul A Latimer; Joshua M Hare; Eric N Olson; Eva van Rooij
Journal:  Circ Res       Date:  2011-11-03       Impact factor: 17.367

9.  Serum- and glucocorticoid-induced protein kinase 1 (SGK1) is regulated by store-operated Ca2+ entry and mediates cytoprotection against necrotic cell death.

Authors:  Deanna R Brickley; Abena S Agyeman; Richard F Kopp; Ben A Hall; Mark C Harbeck; Larissa Belova; Paul A Volden; Wei Wu; Michael W Roe; Suzanne D Conzen
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

10.  miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway.

Authors:  Jincheng Li; Stefan Donath; Yanrui Li; Danian Qin; Bellur S Prabhakar; Peifeng Li
Journal:  PLoS Genet       Date:  2010-01-08       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.